FIELD: biotechnology.
SUBSTANCE: method includes dilution of 55 mg of "KS" vaccine were dissolved in 3 ml of petroleum ether and dispersed into a sodium alginate suspension in petroleum ether containing 550 mg of this polymer in the presence of 60 mg of E472s preparation as surfactant while stirring at 1000 rpm, then 5 ml of ethyl acetate is added, the precipitate is filtered and dried at room temperature.
EFFECT: simplification and acceleration of "KS" vaccine nanocapsules production process, increasing their output by weight.
1 dwg, 1 tbl, 3 ex
